Shinpoong Linagliptin Tablet 5mg
Linagliptin 5mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
MFDS item code 202200559 · Approved 2022.02.07
This product's status changed to Approval withdrawn on 2024.04.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood sugar control in type 2 diabetes
This medication is used to improve blood sugar control in patients with type 2 diabetes by assisting with diet and exercise. It can be taken alone or in combination with other diabetes medications to enhance effectiveness. This helps to manage blood sugar more reliably.
The recommended dose of this medication is 5mg once a day. It can be administered regardless of meals.
This medication should not be used in patients who have a hypersensitivity to the active ingredient or other components. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Use with insulin or sulfonylureas, which can induce hypoglycemia, may increase the risk of hypoglycemia, so caution is required. Use of this medication is not recommended for patients with heart failure, particularly those with severe heart failure, and should be administered with care in mild heart failure cases. Acute pancreatitis may occur while taking this medication, so if persistent and severe abdominal pain arises, you must stop taking it immediately and consult a physician. A skin condition known as bullous pemphigoid may develop; therefore, if blisters or skin irritation appear, you should discontinue use and consult a specialist. Various adverse reactions have been reported, including hypoglycemia, infections, urticaria, rashes, constipation, and oral ulcers, so you must inform your doctor of any symptoms. Pregnant or breastfeeding women should avoid using this medication and consult a healthcare professional if necessary. Safety in children has not been established, so it should not be used in pediatric patients. Elderly patients and those with impaired renal or liver function may use it without specific dose adjustments, but their conditions should be monitored carefully. In the case of overdose, measures should be taken to prevent drug absorption in the gastrointestinal tract and symptoms should be observed, administering appropriate treatment if necessary. This medication should be kept out of reach of children and special care should be taken not to transfer it to other containers, as this can affect its quality and safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a sealed container. It is preferable to maintain storage temperatures between 1°C and 30°C. Avoid storing in excessively hot or cold places.
Red round film-coated tablet with both sides convex and edges sharp.
30 tablets/box [30 tablets (10 tablets / PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin 5mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Linagliptin 5mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.